Deutsche Bank Aktiengesellschaft Begins Coverage on Smith & Nephew (NYSE:SNN)

Deutsche Bank Aktiengesellschaft initiated coverage on shares of Smith & Nephew (NYSE:SNN) in a research note issued to investors on Wednesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating on the medical equipment provider’s stock.

Several other equities analysts have also recently commented on the company. StockNews.com cut Smith & Nephew from a strong-buy rating to a buy rating in a research report on Monday, May 13th. UBS Group raised shares of Smith & Nephew from a neutral rating to a buy rating in a research note on Wednesday, June 5th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Smith & Nephew currently has an average rating of Moderate Buy.

Smith & Nephew Price Performance

Shares of Smith & Nephew stock opened at $28.93 on Wednesday. The stock’s 50-day simple moving average is $26.21 and its 200 day simple moving average is $26.33. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.72 and a current ratio of 1.77. Smith & Nephew has a 52-week low of $21.52 and a 52-week high of $31.17.

Hedge Funds Weigh In On Smith & Nephew

Hedge funds and other institutional investors have recently modified their holdings of the company. CWM LLC lifted its stake in Smith & Nephew by 68.6% in the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 388 shares during the period. Spire Wealth Management raised its holdings in Smith & Nephew by 224.3% in the 4th quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 702 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Smith & Nephew by 75.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,227 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 526 shares during the period. Parallel Advisors LLC boosted its stake in shares of Smith & Nephew by 150.9% during the 4th quarter. Parallel Advisors LLC now owns 1,533 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 922 shares in the last quarter. Finally, Mather Group LLC. increased its position in shares of Smith & Nephew by 9,735.3% during the second quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 1,655 shares during the period. 25.64% of the stock is owned by institutional investors.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.